Agree. A move beyond will be a strong signal. Can’t help but feel very positive though about recent developments. Reality is, Japan licensing deal must be nearly done, US patent just granted opening up the door to yet another manufacturing and licensing deal there, not to mention Sygenus. Timing of announcements will be critical, but then again, RGS still trades thinly and has so far avoided the radars of stock picking analysts. I am hoping we are on the cusp of something very promising.
RGS Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held